New Findings on Xenografts Described by Investigators at Yale University [Ovarian and Uterine Carcinosarcomas Are Sensitive In Vitro and In Vivo To Elimusertib, a Novel Ataxia-telangiectasia and Rad3-related (Atr) Kinase Inhibitor]

Media coverage

• Title	New Findings on Xenografts Described by Investigators at Yale University [Ovarian and Uterine Carcinosarcomas Are Sensitive In Vitro and In Vivo To Elimusertib, a Novel Ataxia-telangiectasia and Rad3-related (Atr) Kinase Inhibitor]
  Media name/outlet	NewsRx Women's Health Daily
  Country/Territory	United States
  Date	14/02/23
  URL	ct.moreover.com/?a=50010444787&p=1gw&v=1&x=5F7kxh1YSuwCygiAl_ZIJg
  Persons	Peter Dottino